Gilead Sciences, Inc. (/ˈɡɪliəd/) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing...

broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. During the COVID‑19...

Annual Report 2017" (PDF). "Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results". "Gilead Sciences Announces Fourth Quarter and...

a 2004 novel by Marilynne Robinson Gilead, a novelette by Zenna Henderson in her Ingathering series Gilead Sciences, an American biopharmaceutical company...

it to be a first-in-class medication. Lenacapavir was developed by Gilead Sciences. The safety and efficacy of lenacapavir were established through a...

2017, Gilead Sciences announced that it would acquire Kite Pharma for $11.9 billion in an all-cash deal, a 29% premium on the share price. Gilead made...

combination is owned by Gilead Sciences in some regions. The European patent EP0915894B1 expired in July 2018, Gilead Sciences wished the patent to be...

named CEO of General Instrument from 1990 to 1993 and chairman of Gilead Sciences from 1997 to 2001. Rumsfeld was appointed secretary of defense for...

Prague, by Antonín Holý, and developed by Gilead Sciences and is marketed with the brand name Vistide by Gilead in the US, and by Pfizer elsewhere. Cidofovir...

zoster virus GSK guanosine analogue RTI 1981 Adefovir Hepatitis B Gilead Sciences RTI 2002 (FDA), 2003 (EU) Amantadine Influenza Influenza A virus M2...

Indian pharma companies that received the licensing agreements from the Gilead Sciences to produce remdesivir. Zydus Cadila's major shareholder remains the...

Winner: The Virgo Queen Challenge Prize: A $5,000 cash tip courtesy of Gilead Sciences Canada 40 2 "Greetings Queenlings" November 28, 2024 (2024-11-28) For...

GS-441524 is a nucleoside analogue antiviral drug which was developed by Gilead Sciences. It is the main plasma metabolite of the antiviral prodrug remdesivir...

signed license agreements with Bristol-Myers Squibb for Atazanavir and Gilead Sciences for Tenofovir as part of their Global Access Programs. In 2012, Roche...

transcriptase inhibitor and is a prodrug of tenofovir. It was developed by Gilead Sciences based on the protide technology of Chris McGuigan and is applied in...

biotechnology company Gilead Sciences. He joined Gilead Sciences in 1990 as vice president for research and development. Gilead is known for developing...

for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences. Immunomedics was founded in July 1982 by David M. Goldenberg. Michael...

the active metabolite. Oseltamivir was discovered by scientists at Gilead Sciences using shikimic acid as a starting point for synthesis; shikimic acid...

company Gilead Sciences led to the investigation of PMPA's potential as a treatment for HIV infected patients. In 1997 researchers from Gilead and the...

2009. Gilead, a White Knight, to Buy CV Therapeutics Menarini press release. 18 June 2013 Memarii Group announces agreement with Gilead Sciences to commercialize...

John F. Milligan is an American former executive who was the CEO of Gilead Sciences, a biotechnology company based in the United States from March 2016...

was first tested in people in 2010. In 2011, Gilead Sciences bought Pharmasset for about $11 billion. Gilead submitted the New Drug Application for sofosbuvir...

At the recent 2024 International AIDS Conference in Munich urged Gilead Sciences to allow Lenacapavir to have generic licensing access to the UN-backed...

(GS-5245, ATV006) is an isobutyric ester prodrug of GS-441524 made by Gilead Sciences that is currently in Phase III trials for the outpatient treatment...

There are many notable companies headquartered in Foster City, such as Gilead Sciences, Zoox, and Replit. Visa and Sledgehammer Games were formerly headquartered...

"Pre-Exposure Prophylaxis (PrEP) for HIV Prevention" (PDF). Gilead Sciences Policy Position. Gilead Sciences. Retrieved 15 December 2017. "HIV prevention drug Truvada...

compound dolutegravir by scientists at Gilead Sciences. In vitro and clinical results were presented by Gilead in the summer of 2016. In 2016, bictegravir...

hepatitis C that was developed by Gilead Sciences. After completing Phase III clinical trials, on February 10, 2014, Gilead filed for U.S. approval of a...

by Gilead Sciences, and subsequently the Indian Patent Office in New Delhi approved the drug. After receiving exclusivity with the patent, Gilead Sciences...

The applicant for this medicinal product is Gilead Sciences Ireland UC. 19 August 2020: FDA rejects Gilead’s filing for approval of filgotinib over toxicity...